Speaker
Regulatory Specialist, US Food & Drug Administration (FDA)
Leslie Wagner, Regulatory Specialist at US Food & Drug Administration (FDA), is speaking at 11th Microbiome Movement USA Summit (Boston, United States of America, 9–11 Nov 2026) in the session “Workshop B: Validating Novel Assay Technologies to Demonstrate Identity Potency & Viability for Regulatory Confidence in Microbiome-Based Therapies”.
9–11 Nov 2026Boston, United States of America
Professor of Microbiology, University of North Carolina - Chapel Hill
Executive Director, Center for Microbiome Innovation
Senior Vice President, Head of Microbiome Clinical & Product Development, Ferring Pharmaceuticals
Senior Director - Research & Development, AOBiome Therapeutics
Principal Investigator, US Food & Drug Administration (FDA)
Chief Scientific Officer, MRM Health
This profile is built from conference programmes published on kongre.net. It has not been claimed or confirmed by Leslie Wagner, and it lists only the talks, sessions and presentations named in those programmes.
Is this you? Claim this profile — every request is read by a person before anything is linked.
To ask for a correction or for this profile to be removed, email [email protected].